LEANORA BRISSETT: Open Payments
NPI 1225753221 · MIDLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,288 in 59 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $192 · 2025 $1,288
Food & beverage: $1,288
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 9 | $278 |
| AstraZeneca Pharmaceuticals LP | 7 | $136 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $124 |
| Novo Nordisk Inc | 6 | $103 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $101 |
| Lilly USA, LLC | 5 | $101 |
| Phathom Pharmaceuticals, Inc. | 3 | $62 |
| Axsome Therapeutics, Inc. | 3 | $60 |
| Astellas Pharma US Inc | 2 | $49 |
| Esperion Therapeutics, Inc. | 3 | $43 |
Products named: IBSRELA, Kerendia, TRINTELLIX, MOUNJARO, BREZTRI, VOQUEZNA, Ozempic, Veozah.
Industry payments across TX — which companies pay providers there.
